<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-10T16:44:39+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-IND-C-SAATHII-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Contribute to the national goals of ending AIDS by 2030, and TB elimination by 2025 - India (01-Apr-2024-31-Mar-2027)</narrative>
    </title>
    <description type="1">
      <narrative>India, TB/HIV, Solidarity and Action Against The HIV Infection in India</narrative>
    </description>
    <description type="2">
      <narrative>Goals: The goal of the project is to contribute to the national goal of ending AIDS by 2030. The program will support NACO's expansion of its new model for a comprehensive continuum of care from prevention to treatment; To reduce morbidity and mortality due to TB and contribute to achieving National TB Program's goal of elimination by 2025. Objectives: Increase the proportion of prison inmates and those at OCS who know their HIV status from 56% to 100% in 10 states/UTs; Increase the proportion of other vulnerable populations (spouses and family members, and partners of PLHIV) who know their HIV status from 43% to 73% in 10 states/UTs; Increase the proportion of HIV-exposed infants who received the virological test within 6 months of birth from 92% to 100% in 10 states/Uts; Increase the proportion of PLHIV LFU to ART Center tracked back with definite outcome from 50% to 98% in 10 states/UTs; Increase the proportion of PLHIV due for VL test that have been tested for VL from 60% to 95%; Increase the pediatric TB case notification in nine states from 59219 (2022) to 74170 (2026-27); Increase the pediatric TB treatment success rate in nine states from 90% (2021) to 92% (2026-27); Increase the annual TB case notification by 4564 in 60 districts of 8 states through deployment of portable handheld X-ray device as part of TB case finding activities; Increase the annual TB case notification among the prisoners from 18 to 142 in 10 states and UTs by March 2027.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
    </participating-org>
    <other-identifier ref="IND-C-SAATHIIP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-04-01" />
    <activity-date type="2" iso-date="2024-04-01" />
    <activity-date type="3" iso-date="2027-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Gyongyver Jakab</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>gyongyver.jakab@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="IN" percentage="100">
      <narrative>India</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="42.4">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="36.36">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="21.24">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="97e87d65-a4de-4357-81ae-2aae27b112a2" percentage="0.06">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; HIV prevention communication, information and demand creation for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="a120a70d-52df-43de-97e1-765d63db4170" percentage="7.43">
        <description>
          <narrative>HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; HIV prevention communication, information and demand creation for prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="34.91">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="30.26">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="80d429dc-894d-4f0c-99cc-2403b8f1f5fe" percentage="4.48">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: HRH planning, management and governance including for community health workers (CHWs)</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="1.63">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="1da38701-f878-40c8-aeaf-621a89991324" percentage="0.14">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="14.64">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="8d2f8312-6339-4e40-9c64-84e09bb628b3" percentage="6.45">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Urban poor/slum dwellers</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">4972634.54</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">9612656.99</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">6997048.43</value>
    </budget>
    <capital-spend percentage="1.66" />
    <transaction ref="c11f6eb1-a254-4c75-97ef-f5f7a919ad69">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-09" />
      <value currency="USD" value-date="2024-04-09">14521777.00</value>
      <description>
        <narrative>Global Fund commitment to IND-C-SAATHIIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6d5ac54d-18db-485e-a101-077f72f3d6e4">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-11" />
      <value currency="USD" value-date="2024-04-11">1316722.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a0e7f05b-03b6-4dd2-80d7-9af6b59df011">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-15" />
      <value currency="USD" value-date="2024-08-15">2304581.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="86ec5bc7-08bc-48b9-89a7-fc9a4b8db8c9">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-28" />
      <value currency="USD" value-date="2024-11-28">1593149.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="483fb4fe-c2ca-453f-a9f5-028432f8ca10">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-25" />
      <value currency="USD" value-date="2025-02-25">1061861.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="80ba09ec-62d1-4727-bf47-0b99bc043026">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-20" />
      <value currency="USD" value-date="2025-05-20">1693210.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1f8fcd45-6096-4add-86d3-fd3c18feefe0">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">159823.00</value>
      <description>
        <narrative>Global Fund commitment to IND-C-SAATHIIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3010cf69-f9cf-41dc-9c8c-2c04f9762cdd">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">159823.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="44c096d3-b5e3-487d-ac81-fa934952e0d0">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-02" />
      <value currency="USD" value-date="2025-09-02">708779.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8286cac4-695a-48f1-b616-1be73ce76b35">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-02" />
      <value currency="USD" value-date="2025-09-02">8220.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="36b3d1d8-8cf6-48bf-aad4-0c58a485f33c">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">7170887.00</value>
      <description>
        <narrative>Global Fund commitment to IND-C-SAATHIIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f3bb8e9d-0973-4a8e-ab91-1c764ad29b81">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">-5835255.00</value>
      <description>
        <narrative>Global Fund commitment to IND-C-SAATHIIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="34601102-ed87-46b4-a688-8584c5f09fc8">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-28" />
      <value currency="USD" value-date="2025-10-28">2915239.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="baedcb77-0685-4027-a044-86aab1617657">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">8220.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2d1500de-9281-4c29-9b34-4b0de9b12e3f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-10" />
      <value currency="USD" value-date="2026-03-10">914750.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d3fefd0c-1a65-482a-8a0d-e23ada230d08">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-26" />
      <value currency="USD" value-date="2026-05-26">1543470.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="358e3a74-24c2-4f94-838f-4019af90a2b8">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-10" />
      <value currency="USD" value-date="2026-08-10">-1789208.00</value>
      <description>
        <narrative>Global Fund commitment to IND-C-SAATHIIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4c91a2df-ae54-49ee-867c-bc5da59d43d5">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-10" />
      <value currency="USD" value-date="2026-08-10">7354316.00</value>
      <description>
        <narrative>Global Fund commitment to IND-C-SAATHIIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4fc222c0-ce99-4663-a865-1f3530410df1">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-18" />
      <value currency="USD" value-date="2026-08-18">1825900.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-C-SAATHIIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="IND-C-SAATHIIP01-EXP-20250331">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-03-31" />
      <value currency="USD" value-date="2025-03-31">4972634.55</value>
      <description>
        <narrative>Expenditure reported by Solidarity and Action Against The HIV Infection in India for IND-C-SAATHIIP01, Apr 2024 to Mar 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Solidarity and Action Against The HIV Infection in India</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/IND-C-SAATHII" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/IND/2023/Tuberculosis/en/IND-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 3 - Tuberculosis - India - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1448-IND-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-08-21" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/IND/2023/HIV/en/IND-H_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 3 - HIV - India - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1447-IND-H.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-08-21" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 12066; Denominator: 301644; Percentage: 4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 12066; Denominator: 301644; Percentage: 4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 289578; Denominator: 301644; Percentage: 96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 289578; Denominator: 301644; Percentage: 96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 301644.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 431036.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 418809.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 215518.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 215518.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 222106.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 16982.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 205010.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 215846.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 431692.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 473710.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 215846.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 237119.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 16986.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 220043.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 215846.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 215846.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="58.63">
          <comment>
            <narrative>Numerator: 37333; Denominator: 63674.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="60">
            <comment>
              <narrative>Numerator: 9551; Denominator: 15919.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 19102; Denominator: 31838.</narrative>
            </comment>
          </target>
          <actual value="89.07">
            <comment>
              <narrative>Numerator: 19771; Denominator: 22196.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 9551; Denominator: 15919.</narrative>
            </comment>
          </target>
          <actual value="88.43">
            <comment>
              <narrative>Numerator: 9380; Denominator: 10607.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="90" />
          <actual value="96.02">
            <comment>
              <narrative>Numerator: 24736; Denominator: 25760.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="90" />
          <actual value="95.41">
            <comment>
              <narrative>Numerator: 11428; Denominator: 11978.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="95" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="95" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>VT Other-1-Percentage of HIV-exposed infants tested for HIV at 6 months of birth</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>VT Other-1-Percentage of HIV-exposed infants tested for HIV at 6 months of birth</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="92.03">
          <comment>
            <narrative>Numerator: 4598; Denominator: 4996.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="92" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="92" />
          <actual value="85.16">
            <comment>
              <narrative>Numerator: 6682; Denominator: 7846.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="92" />
          <actual value="92.36">
            <comment>
              <narrative>Numerator: 3314; Denominator: 3588.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="95" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="95" />
          <actual value="94.46">
            <comment>
              <narrative>Numerator: 5477; Denominator: 5798.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="95" />
          <actual value="94.28">
            <comment>
              <narrative>Numerator: 2934; Denominator: 3112.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="18" />
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="65" />
          <actual value="180" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="32" />
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="33" />
          <actual value="105" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="131" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="289" />
          <actual value="321" />
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="158" />
          <actual value="173" />
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="184" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="210" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="60.32">
          <comment>
            <narrative>Numerator: 441673; Denominator: 732255.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="75" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="75" />
          <actual value="95.32">
            <comment>
              <narrative>Numerator: 378528; Denominator: 397095.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="75" />
          <actual value="95.32">
            <comment>
              <narrative>Numerator: 378528; Denominator: 397095.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="85" />
          <actual value="86.52">
            <comment>
              <narrative>Numerator: 65861; Denominator: 76122.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="85" />
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="85" />
          <actual value="86.52">
            <comment>
              <narrative>Numerator: 65861; Denominator: 76122.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="95" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="95" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TBDT Other-1 Number of pediatric patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB.</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>TBDT Other-1 Number of pediatric patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB.</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="55114" />
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="64756" />
          <actual value="58058" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="31449" />
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="33307" />
          <actual value="26194" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="36448" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="75860" />
          <actual value="65365" />
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="39412" />
          <actual value="30321" />
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="43709" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="43709" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TBDT Other-2 Treatment success rate- all forms: Percentage of pediatric patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among pediatric TB patients notified during a specified period; *includes only those with new and relapse TB.</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>TBDT Other-2 Treatment success rate- all forms: Percentage of pediatric patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among pediatric TB patients notified during a specified period; *includes only those with new and relapse TB.</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="89.91">
          <comment>
            <narrative>Numerator: 42039; Denominator: 46759.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="90.8">
            <comment>
              <narrative>Numerator: 55394; Denominator: 61040.</narrative>
            </comment>
          </target>
          <actual value="95.11">
            <comment>
              <narrative>Numerator: 49665; Denominator: 52219.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="90.5">
            <comment>
              <narrative>Numerator: 27621; Denominator: 30520.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="91">
            <comment>
              <narrative>Numerator: 27773; Denominator: 30520.</narrative>
            </comment>
          </target>
          <actual value="94.5">
            <comment>
              <narrative>Numerator: 21371; Denominator: 22615.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="91.5">
            <comment>
              <narrative>Numerator: 28776; Denominator: 31449.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="91.8">
            <comment>
              <narrative>Numerator: 59418; Denominator: 64756.</narrative>
            </comment>
          </target>
          <actual value="93.98">
            <comment>
              <narrative>Numerator: 50768; Denominator: 54021.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="92">
            <comment>
              <narrative>Numerator: 30642; Denominator: 33307.</narrative>
            </comment>
          </target>
          <actual value="93.7">
            <comment>
              <narrative>Numerator: 23710; Denominator: 25305.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="92.5">
            <comment>
              <narrative>Numerator: 33714; Denominator: 36448.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="92.5">
            <comment>
              <narrative>Numerator: 36456; Denominator: 39412.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TCS Other-1 Percentage of PLHIV on ART who are Lost to follow up (LFU)  tracked with definite outcome</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>TCS Other-1 Percentage of PLHIV on ART who are Lost to follow up (LFU)  tracked with definite outcome</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="50.15">
          <comment>
            <narrative>Numerator: 1699; Denominator: 3388.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="70" />
          <actual value="53.08">
            <comment>
              <narrative>Numerator: 28256; Denominator: 53237.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="70" />
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="70" />
          <actual value="53.08">
            <comment>
              <narrative>Numerator: 28256; Denominator: 53237.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2026-03-31" />
          <target value="80" />
          <actual value="80.72">
            <comment>
              <narrative>Numerator: 51553; Denominator: 63868.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="80" />
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="80" />
          <actual value="80.72">
            <comment>
              <narrative>Numerator: 51553; Denominator: 63868.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="90" />
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>